[1] Gazyakan E, Lee CY, Wu CT, Tsao CK, Craft R, Henry SL, Cheng MH, Lee ST. Indications and outcomes of prophylactic and therapeutic extracranial-to-intracranial arterial bypass for cerebral revascularization[J]. Plast Peconstr Surg Glob Open, 2015, 3:e372. [2] Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle Willis; Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)[J]. Neurol Med Chir (Tokyo), 2012, 52:245-266. [3] Yamada S, Oki K, Itoh Y, Kuroda S, Houkin K, Tominaga T, Miyamoto S, Hashimoto N, Suzuki N; Research Committee on Spontaneous Occlusion of Circle of Willis (Moyamoya Disease). Effects of surgery and antiplatelet therapy in ten-year follow-up from the registry study of research committee on moyamoya disease in Japan[J]. J Stroke Cerebrovasc Dis, 2016, 25:340-349. [4] Acker G, Fekonja L, Vajkoczy P. Surgical management of moyamoya disease[J]. Stroke, 2018, 49:476-482. [5] Kim JS. Moyamoya disease:epidemiology, clinical features, and diagnosis[J]. J Stroke, 2016, 18:2-11. [6] Kuroda S; AMORE Study Group. Asymptomatic moyamoya disease:literature review and ongoing AMORE study[J]. Neurol Med Chir (Tokyo), 2015, 55:194-198. [7] Kuroda S, Houkin K. Moyamoya disease:current concepts and future perspectives[J]. Lancet Neurol, 2008, 7:1056-1066. [8] Bower RS, Mallory GW, Nwojo M, Kudva YC, Flemming KD, Meyer FB. Moyamoya disease in a primarily white, midwestern US population:increased prevalence of autoimmune disease[J]. Stroke, 2013, 44:1997-1999. [9] Irikura K, Miyasaka Y, Kurata A, Tanaka R, Yamada M, Kan S, Fujii K. The effect of encephalo-myo-synangiosis on abnormal collateral vessels in childhood moyamoya disease[J]. Neurol Res, 2000, 22:341-346. [10] Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, Nakagawara J, Takahashi JC; JAM Trial Investigators. Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease:results of the Japan Adult Moyamoya Trial[J]. Stroke, 2014, 45:1415-1421. [11] Iwama T, Hashimoto N, Miyake H, Yonekawa Y. Direct revascularization to the anterior cerebral artery territory in patients with moyamoya disease:report of five cases[J].Neurosurgery, 1998, 42:1157-1161. [12] Sun Y, Wang BL, Li Q, Tong XG. Clinical analysis of low flow bypass in the treatment of chronic symptomatiz middle cerebral antery occlusion[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2021, 21:547-552.[孙杨, 王本琳, 李琪, 佟小光. 低流量血管搭桥术治疗慢性症状性大脑中动脉闭塞疗效分析[J]. 中国现代神经疾病杂志, 2021, 21:547-552.] [13] Hayashi T, Shirane R, Tominaga T. Additional surgery for postoperative ischemic symptoms in patients with moyamoya disease:the effectiveness of occipital artery-posterior cerebral artery bypass with an indirect procedure:technical case report[J]. Neurosurgery, 2009, 64:E195-196. [14] Teo M, Johnson J, Steinberg GK. Strategies for and outcome of repeat revascularization surgery for moyamoya disease:an American Institutional Series[J]. Neurosurgery, 2017, 81:852- [15] Czabanka M, Peña-Tapia P, Scharf J, Schubert GA, Münch E, Horn P, Schmiedek P, Vajkoczy P. Characterization of direct and indirect cerebral revascularization for the treatment of European patients with moyamoya disease[J]. Cerebrovasc Dis, 2011, 32:361-369. [16] Kim DS, Huh PW, Kim HS, Kim IS, Choi S, Mok JH, Huh CW. Surgical treatment of moyamoya disease in adults:combined direct and indirect vs. indirect bypass surgery[J]. Neurol Med Chir (Tokyo), 2012, 52:333-338. [17] Collar RM, Zopf D, Brown D, Fung K, Kim J. The versatility of the temporoparietal fascia flap in head and neck reconstruction[J]. J Plast Reconstr Aesthet Surg, 2012, 65:141-148. [18] Ravina K, Rennert RC, Strickland BA, Chien M, Carey JN, Russin JJ. Pedicled temporoparietal fascial flap for combined revascularization in adult moyamoya disease[J]. J Neurosurg, 2018, 1:1-7. [19] Wong WW, Hiersche MA, Zouros A, Martin MC. Indirect cerebral revascularization with a temporoparietal fascial flap in pediatric moyamoya patients:a novel technique and review of current surgical options[J]. J Craniofac Surg, 2013, 24:2039-2043. [20] Hayashi T, Shirane R, Fujimura M, Tominaga T. Postoperative neurological deterioration in pediatric moyamoya disease:watershed shift and hyperperfusion[J]. J Neurosurg Pediatr, 2010, 6:73-81. [21] Fujimura M, Kaneta T, Shimizu H, Tominaga T. Cerebral ischemia owing to compression of the brain by swollen temporal muscle used for encephalomyo-synangiosis in moyamoya disease[J]. Neurosurg Rev, 2009, 32:245-249. [22] Fujimura M, Tominaga T. Significance of cerebral blood flow analysis in the acute stage after revascularization surgery for moyamoya disease[J]. Neurol Med Chir (Tokyo), 2015, 55:775-781. |